Publications by authors named "Clement Chung"

Claim this Profile
R
Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapies.
Clement Chung, Katelynn Tran

Am J Health Syst Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care.
Clement Chung

Am J Health Syst Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy.
Clement Chung, David Doan

Eur J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation.
Clement Chung, Godsfavour Umoru

J Oncol Pharm Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current therapies for classic myeloproliferative neoplasms: A focus on pathophysiology and supportive care.
Clement Chung

Am J Health Syst Pharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.
Clement Chung, Vanessa T Y Yeung, Kenneth C W Wong

J Oncol Pharm Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing and combination of current small-molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence?
Clement Chung, Godsfavour Umoru, Karen Abboud, Eleanor Hobaugh

Eur J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic syndromes: A focus on pathophysiology and supportive care.
Clement Chung, Emily Allen, Godsfavour Umoru

Am J Health Syst Pharm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Multidisciplinary Treatment-Related Adverse Effects Detection and Reduction in Patients Undergoing Active Cancer Treatments in Ambulatory Infusion Centers.
Clement Chung, Alison Rome, Monica Desai, Fred Abanonu, Cesar De la Casas

JCO Oncol Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
Clement Chung

Blood Lymphat Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the androgen receptor signaling pathway in advanced prostate cancer.
Clement Chung, Karen Abboud

Am J Health Syst Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation.
Clement Chung

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misconception on the duration of ado-trastuzumab emtansine treatment for HER2-positive early breast cancer.
Clement Chung

Am J Health Syst Pharm· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies.
Clement Chung

Ann Pharmacother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab.
Clement Chung

Ann Pharmacother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer.
Clement Chung

Am J Health Syst Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Clement Chung

J Oncol Pharm Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current targeted therapies in lymphomas.
Clement Chung

Am J Health Syst Pharm· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade.
Clement Chung

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instilling value, quality, and safety through hematology and oncology stewardship.
Clement Chung, Sara Kim, Joseph Bubalo

Am J Health Syst Pharm· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway.
Clement Chung

Am J Health Syst Pharm· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system.
Clement Chung, Shital Patel, Rosetta Lee, Lily Fu, Sean Reilly

Am J Health Syst Pharm· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older adults may not consider life expectancy an important factor in cancer screening.
Clement Chung

CA Cancer J Clin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea.
Clement Chung

CA Cancer J Clin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Clement Chung, Hilary Ma

Pharmacotherapy· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis